Interesting T2DM: FDA News & Diabetes Risk

Slideshow

Our May list includes an app for titration of basal insulin, GI effects of GLP-1 agonists, and lifestyle intervention studies.

We present a selection of interesting news and research for the month of May focusing on type 2 diabetes. See the slide legends for links to the article summaries.

Related Videos
Laxmi Mehta, MD | Credit: American Heart Association
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
Erin Michos, MD | Credit: Johns Hopkins University
Natalie McCormick, PhD | Credit: American College of Rheumatology
Related Content
Stock imagery of diabetes related items. | Credit: Fotolia

ACP's New Type 2 Diabetes Guidance Recommends SGLT2is, GLP-1 RAs as Second-Line to Metformin

April 19th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: 2024 ACP Type 2 Diabetes Recommendations

April 19th 2024
Podcast
Brendon Neuen, MBBS, PhD | Credit: X.Com

SMART-C Meta-Analysis: SGLT2 Inhibitors Reduce Cardiovascular Events

April 18th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

April 17th 2024
Podcast
Manufacturing Costs for Diabetes Medicines Could Likely Be Lower | Image Credit: Harvard University

Manufacturing Costs for Diabetes Medicines Could Likely Be Lower, Study Finds

April 4th 2024
Article
Endocrinology Month in Review: March 2024 thumbnail featuring HCOLive endocrinology logo

Endocrinology Month in Review: March 2024

April 3rd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.